Surmodics, Inc. (SRDX)
USD 30.11
(-2.11%)
USD 30.11
(-2.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.18 Million USD | -92.16% |
| 2023 | 15.15 Million USD | 212.53% |
| 2022 | -12.22 Million USD | -211.74% |
| 2021 | 12.17 Million USD | 1098.97% |
| 2020 | 5.94 Million USD | -90.64% |
| 2019 | 14.16 Million USD | -4.49% |
| 2018 | -1.1 Million USD | 16.72% |
| 2017 | 12.93 Million USD | -67.64% |
| 2016 | 26.41 Million USD | 31.75% |
| 2015 | 21.89 Million USD | -2.24% |
| 2014 | 21.29 Million USD | -1.38% |
| 2013 | 22.18 Million USD | 16.79% |
| 2012 | 19.3 Million USD | -51.93% |
| 2011 | 40.16 Million USD | -0.56% |
| 2010 | -12.84 Million USD | -37.77% |
| 2009 | 65.43 Million USD | 92.62% |
| 2008 | 33.7 Million USD | -13.81% |
| 2007 | 18.88 Million USD | 0.42% |
| 2006 | 39.87 Million USD | -43.07% |
| 2005 | 8.08 Million USD | 136.36% |
| 2004 | 10.47 Million USD | 34.46% |
| 2003 | 20.64 Million USD | 95.25% |
| 2002 | 10.7 Million USD | 78.67% |
| 2001 | 7.56 Million USD | 20.04% |
| 2000 | 6.55 Million USD | 144.71% |
| 1999 | 3.3 Million USD | 110.0% |
| 1998 | 1.7 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.75 Million USD | 2.49% |
| 2024 Q3 | -3.24 Million USD | -201.85% |
| 2024 Q1 | 2.01 Million USD | 525.12% |
| 2023 Q1 | -5.1 Million USD | 9.56% |
| 2023 FY | - USD | 212.53% |
| 2023 Q3 | 23.56 Million USD | 1322.78% |
| 2023 Q2 | -1.92 Million USD | 62.27% |
| 2023 Q4 | -293 Thousand USD | -101.24% |
| 2022 Q1 | -1.06 Million USD | -158.87% |
| 2022 Q2 | -2.57 Million USD | -142.66% |
| 2022 FY | - USD | -211.74% |
| 2022 Q3 | -4.93 Million USD | -91.46% |
| 2022 Q4 | -5.64 Million USD | -14.45% |
| 2021 FY | - USD | 1098.97% |
| 2021 Q3 | -79 Thousand USD | -100.69% |
| 2021 Q2 | 11.38 Million USD | 483.15% |
| 2021 Q1 | 1.95 Million USD | 235.06% |
| 2021 Q4 | 1.8 Million USD | 2383.54% |
| 2020 Q4 | -1.44 Million USD | -148.95% |
| 2020 Q1 | 328 Thousand USD | -94.89% |
| 2020 Q2 | 385 Thousand USD | 17.38% |
| 2020 FY | - USD | -90.64% |
| 2020 Q3 | 2.95 Million USD | 667.27% |
| 2019 Q3 | 1.82 Million USD | 118.44% |
| 2019 Q1 | 1.24 Million USD | -18.64% |
| 2019 Q2 | 835 Thousand USD | -33.09% |
| 2019 FY | - USD | -4.49% |
| 2019 Q4 | 6.42 Million USD | 252.25% |
| 2018 Q4 | 1.53 Million USD | -85.2% |
| 2018 FY | - USD | 16.72% |
| 2018 Q2 | -2.13 Million USD | -171.01% |
| 2018 Q1 | 3.01 Million USD | 25.62% |
| 2018 Q3 | 10.36 Million USD | 584.66% |
| 2017 FY | - USD | -67.64% |
| 2017 Q4 | 2.39 Million USD | 1.1% |
| 2017 Q3 | 2.37 Million USD | 126.67% |
| 2017 Q2 | 1.04 Million USD | -77.92% |
| 2017 Q1 | 4.73 Million USD | -12.86% |
| 2016 Q1 | 6.93 Million USD | 62.78% |
| 2016 Q3 | 8.96 Million USD | 57.52% |
| 2016 Q2 | 5.69 Million USD | -17.9% |
| 2016 Q4 | 5.43 Million USD | -39.36% |
| 2016 FY | - USD | 31.75% |
| 2015 Q3 | 6.51 Million USD | 42.19% |
| 2015 Q4 | 4.25 Million USD | -34.63% |
| 2015 Q1 | 5.66 Million USD | -21.67% |
| 2015 FY | - USD | -2.24% |
| 2015 Q2 | 4.58 Million USD | -19.15% |
| 2014 Q3 | 5.96 Million USD | 45.59% |
| 2014 Q1 | 4.25 Million USD | -40.75% |
| 2014 FY | - USD | -1.38% |
| 2014 Q2 | 4.09 Million USD | -3.8% |
| 2014 Q4 | 7.23 Million USD | 21.29% |
| 2013 Q3 | 4.9 Million USD | -0.41% |
| 2013 Q1 | 4.35 Million USD | -15.92% |
| 2013 Q4 | 7.18 Million USD | 46.51% |
| 2013 Q2 | 4.92 Million USD | 13.22% |
| 2013 FY | - USD | 16.79% |
| 2012 Q1 | 3.82 Million USD | -82.74% |
| 2012 FY | - USD | -51.93% |
| 2012 Q4 | 5.17 Million USD | -3.95% |
| 2012 Q3 | 5.38 Million USD | 9.53% |
| 2012 Q2 | 4.91 Million USD | 28.6% |
| 2011 FY | - USD | -0.56% |
| 2011 Q3 | 4.92 Million USD | 41.39% |
| 2011 Q2 | 3.48 Million USD | -27.72% |
| 2011 Q4 | 22.15 Million USD | 349.5% |
| 2011 Q1 | 4.82 Million USD | -77.89% |
| 2010 FY | - USD | -37.77% |
| 2010 Q3 | 6.73 Million USD | -11.7% |
| 2010 Q4 | 21.81 Million USD | 223.69% |
| 2010 Q2 | 7.63 Million USD | 81.0% |
| 2010 Q1 | 4.21 Million USD | -63.77% |
| 2009 Q3 | 3.86 Million USD | -45.6% |
| 2009 Q1 | 53.75 Million USD | 399.65% |
| 2009 Q2 | 7.1 Million USD | -86.78% |
| 2009 FY | - USD | 92.62% |
| 2009 Q4 | 11.63 Million USD | 200.91% |
| 2008 Q1 | 7.33 Million USD | -58.12% |
| 2008 FY | - USD | -13.81% |
| 2008 Q4 | 10.75 Million USD | 32.81% |
| 2008 Q3 | 8.1 Million USD | 7.94% |
| 2008 Q2 | 7.5 Million USD | 2.25% |
| 2007 Q1 | 7.2 Million USD | -13.01% |
| 2007 FY | - USD | 0.42% |
| 2007 Q4 | 17.52 Million USD | 153.26% |
| 2007 Q3 | 6.91 Million USD | -7.14% |
| 2007 Q2 | 7.45 Million USD | 3.36% |
| 2006 FY | - USD | -43.07% |
| 2006 Q1 | 8.73 Million USD | -9.22% |
| 2006 Q2 | 13.53 Million USD | 55.01% |
| 2006 Q3 | 8.38 Million USD | -38.01% |
| 2006 Q4 | 8.28 Million USD | -1.2% |
| 2005 FY | - USD | 136.36% |
| 2005 Q4 | 9.61 Million USD | 0.33% |
| 2005 Q3 | 9.58 Million USD | -76.05% |
| 2005 Q2 | 40.02 Million USD | 334.3% |
| 2005 Q1 | 9.21 Million USD | 5.22% |
| 2004 FY | - USD | 34.46% |
| 2004 Q4 | 8.76 Million USD | 48.52% |
| 2004 Q1 | 6.9 Million USD | -5.01% |
| 2004 Q2 | 7.37 Million USD | 6.85% |
| 2004 Q3 | 5.89 Million USD | -20.03% |
| 2003 Q3 | 6.95 Million USD | 69.15% |
| 2003 Q2 | 3.99 Million USD | 55.01% |
| 2003 Q1 | 2.85 Million USD | -23.74% |
| 2003 Q4 | 7.6 Million USD | 0.55% |
| 2003 FY | - USD | 95.25% |
| 2002 FY | - USD | 78.67% |
| 2002 Q4 | 4.13 Million USD | 17.15% |
| 2002 Q3 | 2.9 Million USD | 25.71% |
| 2002 Q2 | 2.38 Million USD | 31.3% |
| 2002 Q1 | 2.29 Million USD | -24.58% |
| 2001 Q1 | 1.71 Million USD | -48.53% |
| 2001 FY | - USD | 20.04% |
| 2001 Q4 | 3.25 Million USD | 65.53% |
| 2001 Q3 | 2.31 Million USD | 18.34% |
| 2001 Q2 | 2.1 Million USD | 36.17% |
| 2000 Q2 | 1.47 Million USD | 7.55% |
| 2000 Q1 | 1.4 Million USD | -15.38% |
| 2000 FY | - USD | 144.71% |
| 2000 Q4 | 2.3 Million USD | 73.72% |
| 2000 Q3 | 1.36 Million USD | -12.17% |
| 1999 Q1 | 400 Thousand USD | 0.0% |
| 1999 Q3 | 1 Million USD | 100.0% |
| 1999 Q2 | 808 Thousand USD | 400.0% |
| 1999 FY | - USD | 110.0% |
| 1999 Q4 | 1.1 Million USD | 30.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | 400 Thousand USD | -66.67% |
| 1998 Q2 | 600 Thousand USD | -73.68% |
| 1998 Q1 | 1.9 Million USD | 0.0% |
| 1998 Q3 | 500 Thousand USD | -40.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 108.808% |
| Cerus Corporation | -26.53 Million USD | 104.477% |
| OrthoPediatrics Corp. | -8.38 Million USD | 114.175% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 111.32% |
| Talis Biomedical Corporation | -66.04 Million USD | 101.799% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 107.124% |
| Inogen, Inc. | -45.67 Million USD | 102.601% |
| Spectral AI, Inc. | -12.26 Million USD | 109.688% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 102.491% |
| CVRx, Inc. | -38.73 Million USD | 103.067% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 133.673% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 109.813% |
| Orthofix Medical Inc. | -86.98 Million USD | 101.366% |
| Venus Concept Inc. | -26.11 Million USD | 104.549% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 102.387% |
| Bioventus Inc. | -23.07 Million USD | 105.15% |
| BrainsWay Ltd. | -2.31 Million USD | 151.406% |
| Envoy Medical, Inc. | -18.23 Million USD | 106.514% |
| electroCore, Inc. | -17.76 Million USD | 106.689% |
| IceCure Medical Ltd | -15.25 Million USD | 107.789% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 102.388% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 107.048% |
| MaxCyte, Inc. | -44.12 Million USD | 102.692% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 110.105% |
| Nexalin Technology, Inc. | -5.69 Million USD | 120.871% |
| PAVmed Inc | -75.74 Million USD | 101.568% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 102.21% |
| RxSight, Inc. | -41.03 Million USD | 102.895% |
| Sight Sciences, Inc. | -49.41 Million USD | 102.404% |
| SI-BONE, Inc. | -34.44 Million USD | 103.449% |
| TELA Bio, Inc. | -40.63 Million USD | 102.924% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 102.038% |
| Treace Medical Concepts, Inc. | -39 Million USD | 103.046% |
| LivaNova PLC | 39.01 Million USD | 96.955% |
| 908 Devices Inc. | -34.02 Million USD | 103.492% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 101.074% |
| Nemaura Medical Inc. | -7.28 Million USD | 116.303% |
| NeuroPace, Inc. | -22.83 Million USD | 105.203% |
| LENSAR, Inc. | -8.71 Million USD | 113.633% |
| Apyx Medical Corporation | -18.11 Million USD | 106.559% |
| Cutera, Inc. | -136.56 Million USD | 100.87% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 135.148% |
| BioSig Technologies, Inc. | -28.15 Million USD | 104.22% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 52.782% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 105.66% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 99.69% |
| Axonics, Inc. | 7.77 Million USD | 84.72% |
| Outset Medical, Inc. | -153.78 Million USD | 100.772% |
| IRIDEX Corporation | -7.44 Million USD | 115.951% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 101.211% |
| IRadimed Corporation | 20.8 Million USD | 94.289% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 114.736% |
| INVO Bioscience, Inc. | -6.88 Million USD | 117.267% |
| Telesis Bio, Inc. | -40.49 Million USD | 102.934% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 96.761% |
| Varex Imaging Corporation | 67.2 Million USD | 98.232% |
| Quipt Home Medical Corp. | 44.07 Million USD | 97.304% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 110.929% |
| Pulmonx Corporation | -55.09 Million USD | 102.156% |
| Dynatronics Corporation | -976 Thousand USD | 221.72% |
| Modular Medical, Inc. | -17.1 Million USD | 106.946% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 108.202% |
| Semler Scientific, Inc. | 23.58 Million USD | 94.964% |
| InMode Ltd. | 196.28 Million USD | 99.395% |
| Bruker Corporation | 599 Million USD | 99.802% |
| Cytosorbents Corporation | -28.81 Million USD | 104.123% |
| DexCom, Inc. | 916.7 Million USD | 99.87% |
| Align Technology, Inc. | 799.03 Million USD | 99.851% |
| Viveve Medical, Inc. | -20.61 Million USD | 105.762% |
| ZimVie Inc. | 91.07 Million USD | 98.696% |
| Movano Inc. | -29.12 Million USD | 104.079% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 126.951% |
| Nexalin Technology, Inc. | -5.69 Million USD | 120.871% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 133.673% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 100.61% |
| Profound Medical Corp. | -27.12 Million USD | 104.38% |
| Insulet Corporation | 323.6 Million USD | 99.633% |
| enVVeno Medical Corporation | -25.01 Million USD | 104.749% |
| iCAD, Inc. | -6.56 Million USD | 118.096% |
| Nuwellis, Inc. | -16.35 Million USD | 107.263% |
| Biotricity, Inc. | -8.82 Million USD | 113.457% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 101.226% |
| Aethlon Medical, Inc. | -11.84 Million USD | 110.026% |
| InspireMD, Inc. | -20.91 Million USD | 105.681% |
| PAVmed Inc. | -75.74 Million USD | 101.568% |
| BIOLASE, Inc. | -15.13 Million USD | 107.847% |
| Beyond Air, Inc. | -59.03 Million USD | 102.013% |
| FONAR Corporation | 28.25 Million USD | 95.795% |
| AxoGen, Inc. | -13.32 Million USD | 108.914% |
| Vivani Medical, Inc. | -26.6 Million USD | 104.465% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 95.159% |
| Inari Medical, Inc. | 7.11 Million USD | 83.298% |
| UFP Technologies, Inc. | 72.74 Million USD | 98.367% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 135.088% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 119.298% |
| Tenon Medical, Inc. | -15.52 Million USD | 107.651% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 107.782% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 102.864% |
| AdaptHealth Corp. | -171.09 Million USD | 100.694% |
| Sintx Technologies, Inc. | -6.6 Million USD | 118.0% |
| NanoVibronix, Inc. | -3.43 Million USD | 134.585% |
| Quanterix Corporation | -38.08 Million USD | 103.119% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 110.929% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -3860.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 100.428% |
| TransMedics Group, Inc. | -7.6 Million USD | 115.625% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 105.458% |
| NeuroMetrix, Inc. | -7.09 Million USD | 116.742% |
| Hyperfine, Inc. | -47.06 Million USD | 102.524% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 102.037% |
| Biomerica, Inc. | -5.99 Million USD | 119.823% |
| Bone Biologics Corporation | 479.57 Thousand USD | -147.721% |
| AVITA Medical, Inc. | -39.56 Million USD | 103.002% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 112.951% |
| Silk Road Medical, Inc | -45.08 Million USD | 102.635% |